The Market for RNA Sequencing, 3rd Edition

Published: September 8, 2023 | Price: $5,000.00 – $10,000.00

The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future.  In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas.  In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it.  Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...

Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition

Published: July 13, 2023 | Price: $3,750.00 – $7,500.00

A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States, 6th Edition examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type,...

Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals

Published: May 22, 2023 | Price: $5,000.00 – $10,000.00

This report, Kalorama's Cell and Gene Deals and Market Analysis, tracks the dealmaking and market opportunity in cell and gene therapy.   The report includes specific details of 1000+ deals from 2022-2023.   A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently. Kalorama's CGT deals amounted to a staggering $40 billion in 2022.  Understanding the deals that have been made, who is making them, and what the specific details are is critical to...

COVID-19 Testing Markets, 2023

Published: April 24, 2023 | Price: $5,000.00 – $10,000.00

Covid-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in COVID-19 Testing Markets, 2023. The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of...

Hematology and Coagulation Markets, 2023

Published: April 6, 2023 | Price: $3,750.00 – $7,000.00

SKU 23-708: There is a nearly $10 billion-dollar market for hematology and coagulation IVD testing.  Increasingly growth is driven by new technologies, the aging population, and the demand for decentralized testing.   This report provides: Market sizing for Hematology IVD and Coagulation IVD Markets for Decentralized and Lab-based Segments. Forecasts to 2027 Market Share Country Markets for Hematology (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States) Country Markets for Coagulation (Australia, Brazil, Canada, China,...

The Worldwide Market for In Vitro Diagnostic Tests, 15th Edition

Published: March 20, 2023 | Price: $7,000.00 – $14,000.00

For Two Decades, One Volume Has Offered Complete Coverage of The IVD Industry Now with a March 2023 Addendum The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry.  Having a guide for the state of IVD and its future is a vital part of making well-informed decisions. The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates,...

The Market and Future Potential for Molecular Point of Care (mPOC), 2023

Published: February 7, 2023 | Price: $5,000.00 – $10,000.00

This report is an essential tool for understanding the size and growth opportunity in molecular POC.  Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market.  The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market.  Knowing these markets is essential to knowing the opportunity in point of care testing and microbiology IVD. Since 2013, Kalorama has been producing a dedicated...

The Market for In Vitro Diagnostic (IVD) Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and Other Nations)

Published: January 23, 2023 | Price: $5,000.00 – $10,000.00

This report, The Market for In Vitro Diagnostic (IVD) Tests in Latin America, focuses on the market for reagents and instruments in the most important countries of the region. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis; the countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay were also considered to provide a complete overview of the region. Combined, these...

The World Market for Liquid Biopsy, 2023

Published: December 29, 2022 | Price: $6,000.00 – $12,000.00

Dramatic changes have occurred in the liquid biopsy market, necessitating a resource to provide perspective on the market opportunity. This new report from Kalorama assesses the Liquid Biopsy Market now and in 2027.  The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships. Liquid biopsy is gaining acceptance each year.  Even through the COVID-19 pandemic, announcements of new liquid biopsy products were made and studies conducted to...

The Market for Medical Devices, 12th Edition

Published: November 9, 2022 | Price: $5,000.00 – $10,000.00

The medical device industry, often referred to as the medtech industry, is an important aspect of the entire healthcare industry. The medical device industry is constantly updating and changing through the continued development of new technologies, equipment, tests and devices. Advancements in the medical device markets are life-changing and are allowing patients to live longer, healthier and more productive lives. However, the medical device industry has unique challenges. It is a heavily regulated industry in most nations of the world,...

Precision Cancer Therapeutics Market, 2022

Published: October 25, 2022 | Price: $5,000.00 – $10,000.00

Despite advances in cancer treatment, cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry.  Worldwide between 35 and 40 million people are living with cancer and nearly 10 million people lose the battle annually.  The most common cancers affecting the world population include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. Cancer deaths occur in about 50% of people who develop cancer in...

United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition

Published: October 6, 2022 | Price: $5,000.00 – $10,000.00

The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition, discusses the trends shaping the present and future of the IVD...

The Market for RNA Sequencing, 2nd Edition

Published: September 7, 2022 | Price: $0.00 – $9,000.00

The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future.  In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas.  In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it.  Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...

Single Cell Analysis Survey

Published: August 29, 2022 | Price: $7,500.00

This report, produced by Bioinformatics Inc. (not part of Kalorama subscriptions) is a recent survey of  350 respondents from North America, Europe and Asia Pacific that use social media and/or science-related websites for personal or professional purposes participated in this study Readers of this study will understand: Understand the technologies used for isolation of single cells in 2022 Evaluate the kit and instrument suppliers used for single cell experiments Understand the pain points currently experienced with single cell experiments and areas...

Benchmarking for 2022: Understanding the IVD Customer Experience

Published: August 19, 2022 | Price: $6,000.00 – $12,000.00

Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price. This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their customers. Kalorama conducted a 2022 survey of laboratory instrument users in the United States, Canada and Europe (included in respondents are lab managers, lab directors, clinical...

In Vitro Diagnostics (IVD) in India

Published: June 29, 2022 | Price: $5,000.00 – $10,000.00

This new report from Kalorama Information is designed to provide an overview of the IVD market in India and its influences.  The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments: Clinical Chemistry: routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC). Includes urinalysis and blood chemistry testing. Immunoassays: hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology and common infectious diseases (HIV, hepatitis,...

In Vitro Diagnostics (IVD) in the Middle East and Africa

Published: May 27, 2022 | Price: $5,000.00 – $10,000.00

There has been an increasing standard of living in the Middle East and Africa due to higher national income. This has contributed to a higher incidence of heart disease - high blood pressure, high cholesterol and high blood sugar. In fact, the Middle East/Africa region is one of the higher areas for heart disease which has prompted more individuals being admitted to the hospital. This has caused an uptick in the demand for diagnostic testing devices and medical devices. This...

Histology and Cytology IVD Market Update

Published: May 20, 2022 | Price: $5,000.00 – $10,000.00

This report, Histology and Cytology IVD Market Update, provides competitive analysis of the histology/cytology market from 2021 to 2026. Histology/cytology has been a mainstay of the pathological lab, providing information about cells, tissues and organs. A variety of diseases can be identified with a histopathological examination.  Physicians rely on information from the pathologist as to whether there is cancer present or other disease. The physician bases their treatment and prognosis on the pathological information obtained. Technological advancements have increased the...

The Market for Rx-to-OTC Switches, 8th Edition

Published: May 5, 2022 | Price: $6,000.00 – $12,000.00

More than 700 pharmaceutical products have made the switch from Rx to OTC over the past several decades. The U.S. Rx-to-OTC market has grown into a $13.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, the FDA willingness to work with industry, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective...

The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition

Published: April 28, 2022 | Price: $6,000.00 – $12,000.00

As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations...

Infectious Disease Diagnostic Testing: World Market Analysis

Published: April 7, 2022 | Price: $6,000.00 – $12,000.00

The Most Comprehensive and Reliable Market Sizing and Forecasts in Infectious Disease IVD   [caption id="attachment_18836" align="aligncenter" width="300"] Attend a WEBINAR on this topic.[/caption]   Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the...

The Market and Future Potential for Molecular Point of Care (POC), 2022

Published: March 24, 2022 | Price: $5,000.00 – $10,000.00

The Market and Future Potential for Molecular Point of Care (POC), 2022 provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while...

IVD Procedure Volumes, 2021-2026

Published: March 22, 2022 | Price: $7,000.00 – $14,000.00

In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s IVD Test Procedure Volumes, 2021-2026 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner. The...